R. Townsend
Directeur Général chez LEXEO THERAPEUTICS, INC.
Fortune : 3 M $ au 31/05/2024
Profil
R.
Nolan Townsend is currently the Chief Executive Officer & Director at Lexeo Therapeutics, Inc., the Director at Biotechnology Innovation Organization, and the Director at Arbor Biotechnologies, Inc. Previously, he served as the Chairman at Life Science Cares New York from 2022 to 2024 and as a Principal at Pfizer Inc. from 2008 to 2020.
He completed his undergraduate degree at the University of Pennsylvania in 2002 and earned an MBA from Harvard Business School in 2007.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
LEXEO THERAPEUTICS, INC.
0,52% | 10/06/2024 | 170 695 ( 0,52% ) | 3 M $ | 31/05/2024 |
Postes actifs de R. Townsend
| Sociétés | Poste | Début |
|---|---|---|
| LEXEO THERAPEUTICS, INC. | Directeur Général | 01/01/2020 |
Arbor Biotechnologies, Inc.
 Arbor Biotechnologies, Inc. BiotechnologyHealth Technology Arbor Biotechnologies, Inc. engages in curating genetic biodiversity and discover novel protein functions from nature. The company was founded by David Arthur Svott, Winston Xia Yan, Feng Zhang and David R. Walt in 2016 and is headquartered in Cambridge, MA. | Directeur/Membre du Conseil | 01/10/2023 |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Directeur/Membre du Conseil | 01/10/2023 |
Anciens postes connus de R. Townsend
| Sociétés | Poste | Fin |
|---|---|---|
| PFIZER, INC. | Corporate Officer/Principal | 01/01/2020 |
Formation de R. Townsend
| University of Pennsylvania | Undergraduate Degree |
| Harvard Business School | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| LEXEO THERAPEUTICS, INC. | Health Technology |
| PFIZER, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Arbor Biotechnologies, Inc.
Arbor Biotechnologies, Inc. BiotechnologyHealth Technology Arbor Biotechnologies, Inc. engages in curating genetic biodiversity and discover novel protein functions from nature. The company was founded by David Arthur Svott, Winston Xia Yan, Feng Zhang and David R. Walt in 2016 and is headquartered in Cambridge, MA. | Health Technology |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Commercial Services |
